21st Austria weekly - Valneva Vienna Stock Exchange 29/12/2023 [pic1]Valneva: Valneva SE a specialty vaccine company today announced that the Company is modifying its financial guidance for 2023. Product sales remains unchanged as do anticipated R&D expenses. The €90 million to €110 of other income related proceeds from potential sale Company’s priority review voucher PRV which was previously expected before year-end now in early 2024.The previous included total revenues and between €220 €260 million. modified 2023 includes stated product revenue €130 €150 million on track achieve well expenses €60 €70 were recently reduced primarily driven by lower than costs closeout COVID-19 activities. Peter Bühler Chief Financial Officer
21st Austria weekly - Wienerberger Valneva Palfinger 09/11/2023 [pic1]Wienerberger: Operating in a persistently challenging macroeconomic environment provider of innovative ecological solutions for the entire building envelope successfully held its ground third quarter 2023 sustaining good performance first two quarters. Compared to record-breaking year 2022 company generated strong results especially view decline demand all relevant end markets with third-quarter revenues at group level € 3 286 million Q3 2022: 3 848 million and operating EBITDA 665 820 million. The continuation established self-help program aimed earnings growth efficiency enhancements contributed satisfactory amount earnings. These solid results once more demonstrate resilience sustainable diversified business model. Given position proven resilience combined profitability-increasing measures is confident delivering very 2023 confirms target 800-820 million.Wienerberger: performance: 1.91% Valnev
21st Austria weekly - Valneva Warimpex RHI Magnesita 30/05/2023 [pic1]Valneva: Valneva. an Austrian/French specialty vaccine company today announces the filing of a regulatory application with Health Canada for marketing approval Company’s single-shot chikungunya candidate VLA1553 in persons aged 18 years and above. This is second VLA1553 filed by Company intends to make additional submissions 2023.Valneva: performance: -3.30% Warimpex: The business operations Warimpex Group
21st Austria weekly - Agrana Austriacard 27/03/2023 [pic1]Agrana: The fruit starch and sugar group Agrana reports a provisional unaudited operating profit for the financial year 2022/2023 of € 158 mn which is therefore significantly higher than Company’s own guidance up to +50% compared prior years 86.5 mn. Group revenue will amount 3.6 billion 2021|22: 2.9 billion. company s Management Board currently forecasts very significant improvement in EBIT during ongoing 2023|24 more +50 %. assumption that consolidated increase by more +10 % up Key uncertainties however remain war Ukraine its consequences company stated.Agrana: performance: 5.83% Holdings: Holdings B2B provider secure data smart cards payment solutions announced appointment Dimitris
21st Austria weekly - DO & CO Strabag Rosenbauer Wolford Andritz 17/02/2023 [pic1]DO & CO: Austrian catering group CO said its nine-month sales more than doubled to 1.04 billion euros compared with 495 million in the same period a year earlier. According company current business is by far strongest terms of revenue Company’s history. The recovery from impacts COVID-19 pandemic that started previous has continued first three quarters 2022/2023. benefited an increase demand across divisions airline catering international event and restaurants lounges Hotels. For 2022/2023 Group achieved profit after income tax 26.72 9.39 on year. management confident it can keep winning tenders all sizes successfully continue growth path.DO&CO: performance: -0.58% Strabag: publicly listed European